Other OTC - Delayed Quote • USD
NovAccess Global Inc. (XSNX)
At close: April 18 at 3:21 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
CURRENCY IN USD | ||||
---|---|---|---|---|
EPS Est. | -- | -- | -- | -- |
EPS Actual | -- | -- | -- | -- |
Difference | -- | -- | -- | -- |
Surprise % | -- | -- | -- | -- |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | XSNX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 0.80% |
Next Qtr. | -- | -- | -- | 9.60% |
Current Year | -- | -- | -- | 4.50% |
Next Year | -- | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.09% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
ATRX Adhera Therapeutics, Inc.
0.0060
-14.29%
ESLA Estrella Immunopharma, Inc.
1.0300
-8.04%
FRES Fresh2 Group Limited
0.3385
-3.31%
BLPH Bellerophon Therapeutics, Inc.
0.0571
+4.77%
NBSE NeuBase Therapeutics, Inc.
0.4336
+3.26%
AZTR Azitra, Inc.
0.1898
-5.10%
NLSP NLS Pharmaceutics Ltd.
0.1327
-0.23%
THAR Tharimmune, Inc.
0.3778
+0.77%
GRI GRI Bio, Inc.
0.5174
+1.23%
NAMS NewAmsterdam Pharma Company N.V.
19.44
-3.04%